Shares of Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF – Get Free Report) dropped 1% during trading on Wednesday . The stock traded as low as C$4.05 and last traded at C$4.14. Approximately 9,455 shares changed hands during trading, an increase of 28% from the average daily volume of 7,410 shares. The stock had previously closed at C$4.18.
Eupraxia Pharmaceuticals Trading Down 2.9 %
The firm has a fifty day simple moving average of C$3.45 and a 200 day simple moving average of C$3.09.
About Eupraxia Pharmaceuticals
Eupraxia Pharmaceuticals Inc, a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis and eosinophilic esophagitis, as well as under development for treating canine osteoarthritis.
See Also
- Five stocks we like better than Eupraxia Pharmaceuticals
- Are Penny Stocks a Good Fit for Your Portfolio?
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Election Stocks: How Elections Affect the Stock Market
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Which Wall Street Analysts are the Most Accurate?
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Eupraxia Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eupraxia Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
